Coronary interventions

Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials

EuroIntervention 2022;17:1318-1329. DOI: 10.4244/EIJ-D-21-00192

Taku Asano
Taku Asano1, MD, PhD; Masafumi Ono1,2,3, MD; Zhehao Dai4, MD, MPH; Akira Saito1, MD; Takayoshi Kanie1, MD; Yoshimitsu Takaoka1, MD; Atsushi Mizuno1,5,6,7, MD, PhD; Daisuke Yoneoka8, PhD; Nobuyuki Komiyama1, MD, PhD
1. Department of Cardiovascular Medicine, St. Luke’s International Hospital, St. Luke’s International University, Tokyo, Japan; 2. Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; 3. Department of Cardiology, National University of Ireland Galway (NUIG), Galway, Ireland; 4. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; 5. The Penn Medicine Nudge Unit, University of Pennsylvania, Philadelphia, PA, USA; 6. Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; 7. Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA; 8. Division of Biostatistics and Bioinformatics, Graduate School of Public Health, St. Luke’s International University, Tokyo, Japan

Background: With the improvements of percutaneous coronary intervention (PCI) technology and post-PCI patient management, several registry studies reported temporal trends in post-PCI clinical outcomes. However, their results are inconclusive, potentially reflecting region-specific trends, based on site-reported events without external validity.

Aims: This study aimed to investigate temporal trends in post-PCI clinical outcomes in all-comers randomised controlled trials (RCTs) involving coronary stents.

Methods: We performed a systematic review identifying RCTs comparing a clinical outcome as a primary endpoint among different coronary stents with an all-comers design and independent clinical event adjudication, extracting the study start year, patient baseline characteristics, and one- and five-year clinical outcomes. Temporal trends in clinical outcomes (cardiac death, myocardial infarction [MI], target lesion revascularisation [TLR], stent thrombosis [ST]) were assessed using random-effects meta-regression analyses, estimating the relationship between clinical outcomes and study start year.

Results: Overall, 25 all-comers trials (51 device arms, 66,327 patients) conducted between 2003 and 2018 fulfilled the eligibility criteria. Random-effects meta-regression analysis revealed significant decreasing trends in one- and five-year cardiac death, one-year TLR, and five-year ST incidences (relative risk per 10-year increase: 0.69 [0.51-0.92], 0.66 [0.44-0.98], 0.60 [0.41-0.88], and 0.18 [0.07-0.44], respectively). There was no significant trend in myocardial infarction incidences.

Conclusions: This is the first attempt to clarify and quantify the temporal trends of post-PCI outcome incidence. The 15-year improvements in PCI therapy and post-therapeutic patient management are associated with reduced incidences of cardiac death and PCI-related adverse events.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

acs/nste-acsdrug-eluting stentstable angina
Read next article
Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study

Latest news